Previous Close | 8.90 |
Open | 8.90 |
Bid | 8.45 |
Ask | 9.15 |
Strike | 52.50 |
Expire Date | 2024-01-19 |
Day's Range | 8.90 - 8.90 |
Contract Range | N/A |
Volume | |
Open Interest | 371 |
Altria always seems to be on the losing side of settlements when its patrons suffer. Just last month, Altria reached a settlement in which it will pay $235 million to resolve at least 6,000 Juul-related cases.
Altria (NYSE: MO) was once considered a stable dividend play for conservative investors. It's the largest tobacco company in America, it generates steady earnings growth, and it's raised its dividend every year since it spun off its overseas business as Philip Morris International (NYSE: PM) in 2008. Let's see why Altria woefully underperformed the market -- and if it's the right time to buy, sell, or hold its stock.
Altria (MO) closed the most recent trading day at $45.33, moving +1.68% from the previous trading session.
Leading cigarette maker Altria Group (NYSE: MO) saw its net revenue drop 2.9% year over year in the first quarter of 2023, marking the fifth straight quarter of this happening. The stock has been a disaster for investors, down 19% over the past five years while the S&P 500 has climbed 50% during the same period. Does this mean it's time to sell Altria stock and move on?
Altria (MO) acquires NJOY Holdings and accordingly updates its adjusted EPS guidance for the full-year 2023.
RICHMOND, Va., June 01, 2023--ALTRIA COMPLETES ACQUISITION OF NJOY HOLDINGS, INC.; UPDATES 2023 FULL-YEAR EARNINGS GUIDANCE
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
RICHMOND, Va., May 26, 2023--Update on Altria’s Pending Acquisition of Njoy Holdings, Inc.
Recently, Zacks.com users have been paying close attention to Altria (MO). This makes it worthwhile to examine what the stock has in store.
These supercharged income stocks, with yields ranging from 7.2% to 13.6%, have been popular buys for some of Wall Street's brightest money managers.
RICHMOND, Va., May 18, 2023--ALTRIA HOLDS 2023 ANNUAL MEETING OF SHAREHOLDERS; DECLARES REGULAR QUARTERLY DIVIDEND OF $0.94 PER SHARE
This pair of consumer staples companies sit at opposite ends of the yield spectrum, but investors should also consider their risk profiles.
The U.S. Food and Drug Administration (FDA) on Friday issued marketing denial orders to 10 companies which collectively manufacture and market about 6,500 flavored e-liquid and e-cigarette products. The health regulator said these companies cannot market or distribute the products in the U.S. and retailers who sell them risk FDA enforcement action. Any company that wants to legally market a new tobacco product in the United States must receive a written marketing order from FDA.
The health regulator said these companies cannot market or distribute the products in the U.S. and retailers who sell them risk FDA enforcement action. Any company that wants to legally market a new tobacco product in the United States must receive a written marketing order from FDA. The FDA named eight of these companies that received the denial orders, which include Imperial Vapors LLC, Savage Enterprises and Big Time Vapes, among others.
Altria Group Inc said Wednesday that it will pay $235 million to settle at least 6,000 lawsuits accusing it of fueling a teen vaping epidemic through its former investment in e-cigarette maker Juul Labs Inc. It came shortly after San Francisco's public school district finished presenting its case against the company in a jury trial, which will now be cut short. Sarah London, one of the lead attorneys for plaintiffs in the litigation, in a statement said the deal would "provide extraordinary and truly meaningful relief for youth, parents, and governmental organizations nationwide."
(Reuters) -Altria Group Inc said Wednesday that it will pay $235 million to settle at least 6,000 lawsuits accusing it of fueling a teen vaping epidemic through its former investment in e-cigarette maker Juul Labs Inc. It came shortly after San Francisco's public school district finished presenting its case against the company in a jury trial, which will now be cut short. Sarah London, one of the lead attorneys for plaintiffs in the litigation, in a statement said the deal would "provide extraordinary and truly meaningful relief for youth, parents, and governmental organizations nationwide."
RICHMOND, Va., May 10, 2023--Altria Announces Agreement to Resolve Vast Majority of JUUL-Related State and Federal Litigation
Like most tobacco companies, Philip Morris International (NYSE: PM) pays a hefty dividend. Investors should consider adding Philip Morris to their portfolio for the next 10 years. Philip Morris began as the cigarette company with non-U.S. rights to Marlboro when Altria spun it off about 15 years ago.
Altria Group (NYSE: MO) has raised its annual payouts for 53 consecutive years, putting the tobacco giant among just 48 Dividend Kings -- companies that have raised their dividends annually for at least 50 years straight. Let's dig into why the company could be a buy for income-oriented investors. Led by its top-selling Marlboro cigarette brand and secondary brands like Parliament, Altria Group is the unquestioned leader of the U.S. combustible tobacco industry.
RICHMOND, Va., May 04, 2023--Altria to host webcast of 2023 Annual Meeting of Shareholders.
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Of the top five highest-yielding dividend stocks in the S&P 500, none have a yield of less than 7.4%. Here is some information about the five companies to help you decide if investing in them is right for you.
Tobacco giant Altria Group (NYSE: MO) recently gave investors an updated look at the company when it held an investor event in late March. Company management laid out some goals for 2028, though shareholders might have left the event with some unanswered questions. Altria followed this up with its first-quarter earnings report about a month later.
Altria (NYSE: MO) just reported its earnings for the first quarter of 2023, and it seemed to confirm the stock's unstoppability. This is notable since the government and society have actively discouraged tobacco use for decades.
Elite dividend stocks are highly prized assets by investors. Fortunately, quarterly earnings reports offer shareholders a window into the health of a company over the prior three months, as well as an important glimpse into what may be on the near-term horizon. Armed with this insight, here is a brief health check on three popular dividend stocks following their 2023 first-quarter earnings reports last week.